Description:

Strattera is a pharmaceutical product containing the active substance atomoxetine. It is primarily used in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. Unlike stimulant medications commonly used to treat ADHD, atomoxetine is a selective norepinephrine reuptake inhibitor (SNRI) that works by increasing the levels of norepinephrine in the brain, thereby improving attention span, impulse control, and hyperactivity.

Key Points:

• Active Ingredient:
  • Atomoxetine: A selective norepinephrine reuptake inhibitor (SNRI) that increases the levels of norepinephrine in the brain, helping to improve symptoms of ADHD.
• Indications:
  • Strattera is indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children (6 years and older), adolescents, and adults.
• Mechanism of Action:
  • Atomoxetine works by blocking the reuptake of norepinephrine, a neurotransmitter involved in regulating attention, impulse control, and activity levels. By increasing the levels of norepinephrine in the brain, atomoxetine helps improve focus, attention span, and behavioral control in individuals with ADHD.
• Dosage Forms:
  • Strattera is available in oral capsule form, typically supplied in blister packs containing a specific number of capsules.
• Dosage and Administration:
  • The dosage of Strattera is determined by a healthcare professional based on factors such as the patient’s age, weight, and severity of ADHD symptoms. It is usually taken once daily, preferably in the morning or as directed by the healthcare provider.
• Treatment Duration:
  • Strattera is intended for long-term use as part of a comprehensive treatment plan for ADHD. The duration of treatment may vary depending on factors such as the individual’s response to therapy and the presence of comorbid conditions.
• Precautions:
  • Strattera should be used with caution in individuals with a history of heart problems, high blood pressure, or psychiatric disorders. It may also interact with certain medications, so it is important to inform the healthcare provider about all medications being taken.
• Possible Side Effects:
  • Common side effects of Strattera may include nausea, vomiting, insomnia, decreased appetite, and dry mouth. Less common but more serious side effects such as suicidal thoughts, liver problems, and allergic reactions may occur.
• Monitoring:
  • Regular monitoring of blood pressure, heart rate, and psychiatric symptoms is typically conducted during Strattera treatment to assess its effectiveness and monitor for potential side effects.
• Manufacturer:
  • Strattera is manufactured by Eli Lilly and Company, a global pharmaceutical company known for its expertise in neuroscience and mental health medications.
• Legal Status:
  • Strattera is a prescription medication and should only be used under the supervision of a qualified healthcare professional.

Note: Strattera offers an effective non-stimulant treatment option for ADHD, particularly for individuals who do not respond well to or cannot tolerate stimulant medications. Patients should strictly adhere to their healthcare provider’s instructions regarding dosage, administration, and monitoring to achieve optimal symptom control and minimize the risk of adverse effects. Regular follow-up appointments with a healthcare provider are essential for ongoing management of ADHD.